Filing Flows › Adient (ADNT) › Stock forecast & fair value
Adient (ADNT) stock forecast and fair value
Adient (ADNT) trades at $17.07. 11 analysts' median price target is $23.00 (+35%), from $17.00 to $64.00. Across 16 valuation methods the middle fair value is $27.62 (+62%).
Fair value by method
| Method | Low | Point | High | vs price |
|---|---|---|---|---|
| P/E vs peers | $18.28 | $22.88 | $30.28 | +34% |
| P/E vs peers, weighted | $18.52 | $25.86 | $41.21 | +52% |
| P/E vs peers, matched | $17.90 | $23.05 | $30.96 | +35% |
| EV/Sales vs peers | $79.05 | $150.05 | $237.39 | +779% |
| EV/Sales vs peers, weighted | $118.87 | $163.60 | $288.52 | +858% |
| EV/Sales vs peers, matched | $89.21 | $150.05 | $237.39 | +779% |
| Residual income | $18.93 | $19.62 | $20.35 | +15% |
| Analysts' price targets | $17.00 | $26.91 | $64.00 | +58% |
| Owner earnings capitalized | $25.67 | $29.11 | $33.61 | +71% |
| Shareholder yield (dividends + buybacks) | $19.10 | $21.66 | $25.01 | +27% |
Adient's latest quarter
Adient, Q4 FY26: revenue $3.7B (+1% year over year), operating margin -0.1%, net loss $20.0M. The chart follows the revenue to costs, profit and cash.
Questions
What is the price target for ADNT stock?
The median of 11 analysts' 12-month targets is $23.00, +35% from $17.07; the range is $17.00 to $64.00. The average rating is buy.
What is Adient's fair value?
The fair-value methods on Filing Flows (DCF, Monte Carlo, peer multiples and others) put it between $0.00 and $163.60, with a middle value of $27.62 against a price of $17.07. Each method's assumptions are on the page.
Does Adient usually beat earnings estimates?
It beat the consensus EPS estimate in 40% of the quarters on record.
Is ADNT stock a buy?
Filing Flows does not give advice. It shows what analysts expect, what each valuation method implies and the figures behind them, read from SEC filings, so you can judge for yourself.
Updated Nov 8, 2026. Read automatically from SEC filings and public data; errors are possible. Not investment advice.